XML 63 R34.htm IDEA: XBRL DOCUMENT v3.20.4
Equity and Stock-based Compensation (Tables)
12 Months Ended
Dec. 31, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Summary of Common Stock Reserved for Future Issuance

Shares of Common Stock outstanding, shares of stock plans outstanding and shares reserved for future issuance related to stock options and RSU grants and the Company’s Employee Stock Purchase Plan (“ESPP”) purchases are as follows (in thousands):

 

 

 

December 31,

 

 

 

2020

 

 

2019

 

Common stock outstanding

 

 

91,441

 

 

 

87,657

 

Stock options outstanding

 

 

9,290

 

 

 

10,018

 

RSUs outstanding

 

 

1,893

 

 

 

1,483

 

Shares reserved for future stock options and RSUs grant

 

 

7,910

 

 

 

7,725

 

Shares reserved for future ESPP offering

 

 

4,070

 

 

 

3,337

 

Total shares of common stock reserved

 

 

114,604

 

 

 

110,220

 

 

Summary of Stock Option Transactions

Stock option transactions, including forfeited options granted under the 2014 Plan as well as prior plans, are summarized below:

 

 

 

Shares

(In thousands)

 

 

Weighted

Average

Exercise per

Share

 

 

Weighted

Average

Remaining Contractual

Life

(In Years)

 

 

Aggregate

Intrinsic Value

(In thousands)

 

Outstanding at December 31, 2019

 

 

10,018

 

 

$

26.63

 

 

 

 

 

 

 

 

 

Granted

 

 

2,692

 

 

 

31.55

 

 

 

 

 

 

 

 

 

Exercised

 

 

(3,113

)

 

 

10.73

 

 

 

 

 

 

 

 

 

Expired

 

 

(73

)

 

 

39.92

 

 

 

 

 

 

 

 

 

Forfeited

 

 

(234

)

 

 

40.11

 

 

 

 

 

 

 

 

 

Outstanding at December 31, 2020

 

 

9,290

 

 

 

32.94

 

 

 

6.60

 

 

$

86,013

 

Vested and expected to vest, December 31, 2020

 

 

8,929

 

 

 

32.76

 

 

 

6.50

 

 

 

84,125

 

Exercisable at December 31, 2020

 

 

5,576

 

 

$

29.50

 

 

 

5.10

 

 

$

66,943

 

Summary of RSU Activity

The following table summarizes RSU activity:

 

 

Shares

(In thousands)

 

 

Fair Value at Grant

 

Unvested at December 31, 2019

 

 

1,483

 

 

$

49.05

 

Granted

 

 

1,354

 

 

 

29.99

 

Vested

 

 

(813

)

 

 

45.55

 

Forfeited

 

 

(131

)

 

 

39.25

 

Unvested at December 31, 2020

 

 

1,893

 

 

$

37.60

 

 

Schedule of Recorded Stock-Based Compensation Expense

Stock-based compensation expense was recorded directly to research and development and selling, general and administrative expense for the years ended December 31, 2020, 2019 and 2018 was as follows (in thousands):

 

 

 

Years Ended December 31,

 

 

 

2020

 

 

2019

 

 

2018

 

Research and development

 

$

46,229

 

 

$

41,015

 

 

$

30,491

 

Selling, general and administrative

 

 

26,491

 

 

 

25,252

 

 

 

21,651

 

Total stock-based compensation expense

 

$

72,720

 

 

$

66,267

 

 

$

52,142

 

 

Schedule of Assumptions used to Estimate Fair Value of Stock Options Granted and Employee Stock Purchase Plans

The assumptions used to estimate the fair value of stock options granted and ESPPs using the Black-Scholes option valuation model were as follows:

 

 

 

Years Ended December 31,

 

 

2020

 

 

 

2019

 

 

 

2018

 

 

Stock Options

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

 

5.7

 

 

 

 

5.3

 

 

 

 

5.4

 

 

Expected volatility

 

 

67.1

 

%

 

 

68.0

 

%

 

 

67.9

 

%

Risk-free interest rate

 

 

0.8

 

%

 

 

2.4

 

%

 

 

2.7

 

%

Expected dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average estimated fair value

 

$

18.36

 

 

 

$

31.98

 

 

 

$

32.12

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

ESPPs

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Expected term (in years)

 

0.5 - 2.0

 

 

 

0.5 - 2.0

 

 

 

0.5 - 2.0

 

 

Expected volatility

 

47.5 - 77.1

 

%

 

48.1 - 62.1

 

%

 

47.3 - 75.3

 

%

Risk-free interest rate

 

0.1 - 2.9

 

%

 

1.3 - 2.9

 

%

 

0.8 - 2.9

 

%

Expected dividend yield

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average estimated fair value

 

$

17.53

 

 

 

$

19.27

 

 

 

$

16.27